Connect with us

Technology

Exubrion Therapeutics® Appoints Jennifer Kirk to Board of Directors; Names Her CEO

Published

on

ALPHARETTA, Ga., March 18, 2025 /PRNewswire/ — Exubrion Therapeutics, the pioneering company behind Synovetin OA®, an innovative injectable treatment that provides relief for dogs suffering from chronic osteoarthritis, announced today that Jennifer Kirk has been appointed to the company’s Board of Directors and will assume the role of Chief Executive Officer effective May 3, 2025. Synovetin OA utilizes proprietary radiotherapeutic technology to deliver targeted, localized relief, helping dogs regain mobility and live pain-free for up to one year after a single treatment.

Kirk brings more than 28 years of leadership and business transformation experience, including a successful tenure at Medtronic, one of the world’s leading medical technology companies. While at Medtronic, she held key executive leadership roles focusing on finance and operational growth. Her experience navigating complex, high-growth organizations in medtech and other industries uniquely positions her to lead Exubrion Therapeutics.

“We are thrilled to welcome Jennifer to the Exubrion Therapeutics leadership team,” said Laurie McRay, Executive Chair and interim CEO. “Her energy, servant leadership, and extensive business experience make her the ideal person to guide us into our next phase of growth. Her proven ability to lead organizations and create value will be instrumental as we continue advancing our mission. We are fortunate to have her at the helm.”

Throughout her career, Kirk has helped companies transform by fostering a culture of innovation; building high-performing teams; unlocking new growth opportunities; and finding ways to grow revenue and expand margins. She has also led teams that captured over $3.5 billion in savings and value by optimizing operations, streamlining efficiencies and driving strategic investments. Kirk holds an MBA plus additional certifications from Carnegie Mellon and Harvard Business School.

“I am honored and excited to join Exubrion Therapeutics as CEO,” said Kirk. “Synovetin OA is a differentiated technology that has already uniquely transformed the treatment of canine osteoarthritis, delivering real, lasting relief for pets and their families. I’m eager to lead Exubrion Therapeutics into this next phase of growth, not only expanding our reach in the canine market but also unlocking the potential for Synovetin OA to help equine patients and, ultimately, all pets in need of effective osteoarthritis treatment. The opportunity to extend this breakthrough therapy into new areas both domestically and internationally is incredibly exciting, and I look forward to working with the team to make it a reality.”

About Exubrion Therapeutics, Inc.

Exubrion Therapeutics is the developer of Synovetin OA, a breakthrough injectable treatment that provides long-lasting relief for dogs suffering from chronic osteoarthritis. Utilizing proprietary radiotherapeutic technology, Synovetin OA offers targeted, localized therapy to reduce joint inflammation and pain, often providing up to a full year of improved mobility and quality of life with a single treatment. For more information, visit https://activedognow.com/about-exubrion/.   

Studied in canine elbows, Synovetin OA is given by authorized veterinarians. Temporary discomfort in treated joints may occur. Talk to a treating veterinarian near you for more information including what to expect following treatment and visit www.activedognow.com.

Media Contact:
Eric Schreiber, Chief Commercial Officer
(610) 368-0815
eschreiber@exubrion.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/exubrion-therapeutics-appoints-jennifer-kirk-to-board-of-directors-names-her-ceo-302403466.html

SOURCE Exubrion Therapeutics

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

5 Ways to Transfer Photos from Phone to PC 2025-Tenorshare iCareFone

Published

on

By

“Why is it so difficult to move photos and movies from iphone to computer without itunes?” How to transfer pictures from iphone to computer easily? Tenorshare iCareFone 1 Click Transfer!

HONG KONG, April 25, 2025 /PRNewswire/ — iTunes does not support certain file types or devices, and it may transfer slowly, causing problems such as “Your account has been disabled in iTunes” and data loss. So move photos and movies from iphone to computer via itunes can be tricky and risky. Unlike transfer pics from Android to PC, iPhone file transfers are not smooth enough, forcing users to reconsider upgrading.

Why Tenorshare iCareFone (All-in-One Free iOS Backup and File Manager)?

Tenorshare iCareFone is the best way to copy photos and videos from iphone to your computer without iTunes in 2025, offers a user-friendly and easily 1 click transfer operating system, and supports up to transfer high quality contacts, music, videos, messages from iPhone/iPad to Windows or Mac directly, suitable for ordinary users and professional technicians.

Key Features of Tenorshare iCareFone:

No need for iTunes, Multiple Sync: Transfer photos, videos, APP and other data between computer, iPhone and Android with original details.Selective Pick & Transfer: Select specific photos or albums selectively. One-click transfer, simpler operation, non-tech background required.Suitable for large-volume photos and videos Transfer: Safe Transfer Keep all your existing data original quality, keep perfect details.Free download and features: iOS data backup, developer mode, iPhone test, AI wallpaper.Supported Windows 11/10/8.1/8/7, macOS 15/14/13/12, and compatible with all iOS 18/17/16, all iPhone version and iPad, and iPod Touch.

How to Import Photos from iPhone to PC (Windows11/10) Without iTunes?

Step1. Install Tenorshare iCareFone Transfer software on your Windows or Mac

Step2. Select all or individual files or photos you want to export to Mac or Windows, and then click the ‘One-click Export’ button.

Step3. Then Successfully to export photos to your laptop device from iPhone Now!

Other 4 Ways to Transfer photos and videos from your iPhone or iPad to your Mac or PC

Way2. Via USB transfer: Connect iPhone and computer via USB>Click “Start”>Select ‘Import’ then transfer your Photos.

Way3. Transfer Photos via iCloud Photos: Select photos from iPhone to back up to iCloud and upload them on your computer

Way4. Use AirDrop: Open Airdrop to send photos and videos to your Mac quickly.

Way5. Use Hard Disk or SD: Go to the Photos app on your Mac, Copy the Photos and videos to Computer.

In short, these methods require a certain technical background, the quick and simple way is Tenorshare iCareFone. Even if you’re not tech-savvy. Just download iCareFone, follow the steps, and move your photos in seconds.

Press Contact:

Angel Harrison
15889757098
https://www.tenorshare.com/ 

View original content to download multimedia:https://www.prnewswire.com/news-releases/5-ways-to-transfer-photos-from-phone-to-pc-2025-tenorshare-icarefone-302438345.html

SOURCE Tenorshare

Continue Reading

Technology

PredxBio Launches Enhanced SpaceIQ™ Platform with Multiomic Spatial Capabilities Ahead of AACR 2025

Published

on

By

PredxBio today announced the official launch of enhanced SpaceIQ™ platform to integrate brightfield, spatial proteomics and transcriptomics datasets to deliver a unified, high-resolution view of the tumor microenvironment—unlocking new insights into cellular interactions, immune architecture, and mechanisms of therapeutic response and resistance. This milestone launch, timed ahead of the American Association for Cancer Research (AACR) Annual Meeting 2025, will be highlighted by two scientific poster presentations and a spotlight symposium at the conference. The new capabilities of SpaceIQ™ are poised to accelerate insights in cancer biology, improve patient stratification, and drive advances in precision immuno-oncology.

PITTSBURGH, April 25, 2025 /PRNewswire-PRWeb/ — PredxBio today announced the official launch of enhanced SpaceIQ™ platform to integrate brightfield, spatial proteomics and transcriptomics datasets to deliver a unified, high-resolution view of the tumor microenvironment—unlocking new insights into cellular interactions, immune architecture, and mechanisms of therapeutic response and resistance. This milestone launch, timed ahead of the American Association for Cancer Research (AACR) Annual Meeting 2025, will be highlighted by two scientific poster presentations and a spotlight symposium at the conference. The new capabilities of SpaceIQ™ are poised to accelerate insights in cancer biology, improve patient stratification, and drive advances in precision immuno-oncology.

By integrating multiomic spatial data with SpaceIQ™, we are advancing the frontier of precision oncology – translating these insights into actionable solutions for patient care.

SpaceIQ™ is an explainable AI-driven spatial multiomics platform that provides a rigorous framework to interrogate the tumor microenvironment. With its latest upgrade, SpaceIQ™ can now ingest and co-analyze brightfield, spatial proteomics and transcriptomics datasets from tumor samples. Researchers are able to map gene expression profiles onto tissue architecture and identify complex cellular neighborhoods (or “microdomains”) that drive tumor progression and immune evasion. By leveraging probabilistic modeling and unbiased cell typing, SpaceIQ™ uncovers transition cell states, cell–cell interactions, and mechanistic pathway networks within the tumor – yielding a deeper understanding of tumor heterogeneity and therapy resistance.

“PredxBio’s unique capabilities in unbiased cell typing and explainable AI allow us to decode the mechanistic complexities of the tumor microenvironment,” said S. Chakra Chennubhotla, PhD, Chief of AI at PredxBio. “By integrating multiomic spatial data with SpaceIQ™, we are advancing the frontier of precision oncology – translating these insights into actionable solutions for patient care.”

At AACR 2025 in Chicago, PredxBio and its collaborators will present two new studies showcasing SpaceIQ™’s impact:

Poster 1 (Abstract #2485): “A Bayesian Framework for Unraveling Disease Biology from Spatially Resolved Single-Cell Omics Datasets.” Co-authored in collaboration with Arutha Kulasinghe, PhD, Director of the Queensland Spatial Biology Centre, this poster introduces a novel Bayesian approach for analyzing high-dimensional spatial single-cell data. Presentation Time: April 28, 2025, 9:00 AM–12:00 PM CT (Poster Section 47, Board #6). The study demonstrates how combining unbiased computational methods with biological priors in SpaceIQ™ can reveal emergent cell types and microdomains, offering new insights into disease mechanisms.Poster 2 (Abstract #5317): “Multimodal Spatial Analysis of Colon Cancer Tissue Reveals Emergence of an Immunosuppressive Tumor Maintenance Mechanism.” Co-authored by Gaurav N. Joshi, PhD, and colleagues from Nikon BioImaging Lab in Boston, this research applies SpaceIQ™ to a colon cancer sample by integrating mIF and spatial transcriptomics. Presentation Time: April 29, 2025, 2:00 PM–5:00 PM CT (Poster Section 8, Board #23). This study uncovers how tumor and immune cells are spatially organized to create an immunosuppressive microenvironment that supports tumor maintenance.

“Using SpaceIQ’s multiomic analysis, we discovered an immunosuppressive mechanism in colon cancer that would have been difficult to detect with single-modality data,” noted Gaurav N. Joshi, PhD, lead author of the colon cancer study. “By combining brightfield, spatial proteomics and transcriptomics datasets, we can see how different immune cells and signals interact within the tumor microenvironment. This level of insight is invaluable for precision immuno-oncology, as it points to biomarkers and therapeutic targets that can inform more effective, personalized treatments.”

Spotlight Symposium at AACR 2025

The launch of SpaceIQ™ will also be highlighted during a Spotlight Theater Symposium titled:

“Harnessing Spatial Multiomic Biomarkers: Ushering in a New Era of Precision Oncology”

Date: Sunday, April 27, 2025Time: 3:30 PM4:30 PM CTLocation: Spotlight Theater D, McCormick Place, Chicago

The session will begin with a joint presentation by B. Dusty Majumdar, PhD, S. Chakra Chennubhotla, PhD, and A/Prof. Arutha Kulasinghe, followed by a panel discussion featuring spatial biology experts from academia and industry. Attendees will hear how SpaceIQ™ can be applied to decode tumor complexity and guide biomarker discovery, patient stratification, and companion diagnostic development.

Visit PredxBio at AACR 2025

Exhibit Booth: #3252Conference Dates: April 26–30, 2025Venue: McCormick Place, Chicago, IL

Attendees are invited to stop by the booth for hands-on demonstrations and to learn how SpaceIQ™ is enabling faster, more informed decisions in drug development, biomarker discovery, and patient stratification.

About PredxBio

PredxBio is a spatial analytics company headquartered in Pittsburgh, PA, powering next-generation cancer therapeutics with its AI-driven spatial biomarkers. PredxBio’s proprietary approaches delve into the mechanism of action of drugs and predict patient outcomes with over 90% accuracy. By transforming multiplexed biopsy images and multi-modal spatial data into actionable insights – and revealing the network biology of cancer – PredxBio is setting new standards for biomarker discovery and clinical research. In partnership with leading pharmaceutical companies and research institutions, PredxBio is accelerating drug discovery and advancing personalized medicine to impact cancer patients globally. For more information, visit www.predxbio.com

Media Contact

A. Burak Tosun, PredxBio, 1 4122123115, info@predxbio.com, www.predxbio.com

LinkedIn

View original content:https://www.prweb.com/releases/predxbio-launches-enhanced-spaceiq-platform-with-multiomic-spatial-capabilities-ahead-of-aacr-2025-302438004.html

SOURCE PredxBio

Continue Reading

Technology

APAMAN Group Begins Full-Scale Rollout of Impress AI Marketing Video Generator

Published

on

By

Innovative AI solution with proprietary object‑recognition model drives leads, engagement, and revenue – without ad spend

NEW YORK, April 25, 2025 /PRNewswire-PRWeb/ — Impress AI (East Meet East, Inc.) today announced that APAMAN Group (Head Office: Chiyoda-ku, Tokyo, President: Koji Omura) has begun full-scale deployment and marketing of Impress AI, an automatic social-media video generation software across the group.The software will be rolled out in various business areas, including Apaman Network Co.,Ltd., which operates one of Japan’s largest real estate rental franchise businesses within the group, with the aim of enhancing the quality and operational efficiency of video marketing.

 

“This technology empowers our agents to generate high-impact walkthrough videos—without any ad spend—dramatically increasing leads, speeding up closings, and boosting revenue.” — Koji Omura, President & CEO, APAMAN Group.

NEWS HIGHLIGHTS

Rapid Rollout: APAMAN Group kicks off at 42 stores today, targeting 360 locations within one year.Smart Automation: Impress AI’s proprietary object‑recognition model automatically detects key property features – from kitchen fixtures and laundry areas to flooring and architectural details – in smartphone‑shot walkthrough clips, with no specialized hardware or apps required.End‑to‑End Video Production in Minutes: Agents simply upload raw video and basic listing data; Impress AI instantly delivers polished social‑media‑ready videos (captions, voiceover, color correction, and platform‑specific formatting for Instagram, TikTok, and YouTube Shorts).Proven Engagement: Early deployments have driven over 10 million monthly views from a single social‑media account – entirely organically.Growth Objectives: High engagement in social media will drive a significant uplift in lead volume and close rates, while cutting manual editing time

“As we accelerate digital transformation in real‑estate marketing, adopting Impress AI has been a game‑changer,” said Koji Omura, President & CEO of APAMAN Group. “This technology empowers our agents to generate high‑impact walkthrough videos – without any ad spend – dramatically increasing leads, speeding up closings, and boosting revenue.” By integrating Impress AI, APAMAN agents can now tap into a vastly larger pool of prospective tenants organically, while saving thousands of staff hours previously devoted to manual video production.

“Impress AI marks a new era where rich, engaging video content can be produced with minimal human effort,” said Mariko Tokioka, Founder & CEO of Impress AI. “Our unique AI engine not only identifies every room detail but also optimizes content for social‑media virality—helping any real‑estate or consumer‑brand to attract more customers and drive measurable business growth.”

Media Contact

Mariko Tokioka, East Meet East, Inc., 1 (646)481-4011, brian@impressai.io, https://impressai.io

Apaman PR team, APAMAN Co., Ltd., pr@apamanshop.cp.jp, https://apamanshop-hd.co.jp/en/

View original content to download multimedia:https://www.prweb.com/releases/apaman-group-begins-full-scale-rollout-of-impress-ai-marketing-video-generator-302437003.html

SOURCE East Meet East, Inc.

Continue Reading

Trending